Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Czech is available via eTranslation, the European Commission's machine translation service.

Translate to Czech | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

Zobrazit

español (ES) (239.85 KB - PDF)

Zobrazit

čeština (CS) (283.94 KB - PDF)

Zobrazit

dansk (DA) (239 KB - PDF)

Zobrazit

Deutsch (DE) (241.8 KB - PDF)

Zobrazit

eesti (ET) (237.14 KB - PDF)

Zobrazit

ελληνικά (EL) (282.67 KB - PDF)

Zobrazit

français (FR) (245.68 KB - PDF)

Zobrazit

italiano (IT) (238.08 KB - PDF)

Zobrazit

latviešu (LV) (283.06 KB - PDF)

Zobrazit

lietuvių (LT) (251.47 KB - PDF)

Zobrazit

magyar (HU) (253.42 KB - PDF)

Zobrazit

Malti (MT) (265.77 KB - PDF)

Zobrazit

Nederlands (NL) (217.72 KB - PDF)

Zobrazit

polski (PL) (282.55 KB - PDF)

Zobrazit

português (PT) (218.29 KB - PDF)

Zobrazit

română (RO) (242.81 KB - PDF)

Zobrazit

slovenčina (SK) (260.4 KB - PDF)

Zobrazit

slovenščina (SL) (252.65 KB - PDF)

Zobrazit

suomi (FI) (237.94 KB - PDF)

Zobrazit

svenska (SV) (239.22 KB - PDF)

Zobrazit

Product information

български (BG) (1.12 MB - PDF)

Zobrazit

español (ES) (413.23 KB - PDF)

Zobrazit

čeština (CS) (559.01 KB - PDF)

Zobrazit

dansk (DA) (619.26 KB - PDF)

Zobrazit

Deutsch (DE) (409.78 KB - PDF)

Zobrazit

eesti (ET) (394.94 KB - PDF)

Zobrazit

ελληνικά (EL) (1.78 MB - PDF)

Zobrazit

français (FR) (455.26 KB - PDF)

Zobrazit

italiano (IT) (432.39 KB - PDF)

Zobrazit

latviešu (LV) (543.86 KB - PDF)

Zobrazit

lietuvių (LT) (475.04 KB - PDF)

Zobrazit

magyar (HU) (577.53 KB - PDF)

Zobrazit

Malti (MT) (631.26 KB - PDF)

Zobrazit

Nederlands (NL) (419.67 KB - PDF)

Zobrazit

polski (PL) (601.64 KB - PDF)

Zobrazit

português (PT) (402.62 KB - PDF)

Zobrazit

română (RO) (490.98 KB - PDF)

Zobrazit

slovenčina (SK) (616.03 KB - PDF)

Zobrazit

slovenščina (SL) (568.91 KB - PDF)

Zobrazit

suomi (FI) (408.3 KB - PDF)

Zobrazit

svenska (SV) (413.86 KB - PDF)

Zobrazit

Íslenska (IS) (418.64 KB - PDF)

Zobrazit

norsk (NO) (405.73 KB - PDF)

Zobrazit
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 KB - PDF)

Zobrazit

español (ES) (148.22 KB - PDF)

Zobrazit

čeština (CS) (192.56 KB - PDF)

Zobrazit

dansk (DA) (151.57 KB - PDF)

Zobrazit

Deutsch (DE) (152.17 KB - PDF)

Zobrazit

eesti (ET) (147.88 KB - PDF)

Zobrazit

ελληνικά (EL) (200.73 KB - PDF)

Zobrazit

français (FR) (474.14 KB - PDF)

Zobrazit

italiano (IT) (148.51 KB - PDF)

Zobrazit

latviešu (LV) (202.11 KB - PDF)

Zobrazit

lietuvių (LT) (191.42 KB - PDF)

Zobrazit

magyar (HU) (188.69 KB - PDF)

Zobrazit

Malti (MT) (194.75 KB - PDF)

Zobrazit

Nederlands (NL) (151.46 KB - PDF)

Zobrazit

polski (PL) (176.01 KB - PDF)

Zobrazit

português (PT) (151.81 KB - PDF)

Zobrazit

română (RO) (188.05 KB - PDF)

Zobrazit

slovenčina (SK) (195.92 KB - PDF)

Zobrazit

slovenščina (SL) (189.87 KB - PDF)

Zobrazit

suomi (FI) (147.96 KB - PDF)

Zobrazit

svenska (SV) (151.54 KB - PDF)

Zobrazit

Íslenska (IS) (151.76 KB - PDF)

Zobrazit

norsk (NO) (148.31 KB - PDF)

Zobrazit

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page